![Paul Romness](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Romness
Algemeen Directeur bij
OS THERAPIES INCORPORATED
Vermogen: 5 M $ op 31-05-2026
Profiel
Paul A. Romness is the founder of OS Therapies, Inc. since 2018, holding the title of Chairman, President & Chief Executive Officer.
Former positions include Director-State Government Affairs at Amgen, Inc. from 2005 to 2008, Vice President-Government Affairs & Public Policy at Boehringer Ingelheim GmbH from 2008 to 2014, and Principal at PR Strategies from 2005 to 2008.
Education includes an undergraduate degree from American University and a graduate degree from Milken Institute School of Public Health.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-01-2026 | 2.473.000 ( 5,55% ) | 5 M $ | 31-05-2026 |
Actieve functies van Paul Romness
| Bedrijven | Functie | Begin |
|---|---|---|
| OS THERAPIES INCORPORATED | Algemeen Directeur | 12-04-2018 |
Eerdere bekende functies van Paul Romness
| Bedrijven | Functie | Einde |
|---|---|---|
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Algemeen Adviseur | 01-01-2014 |
| AMGEN INC. | Algemeen Adviseur | 01-03-2008 |
PR Strategies | Corporate Officer/Principal | 01-03-2008 |
Opleiding van Paul Romness
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
70
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Health Technology |
American University
 American University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Milken Institute School of Public Health
 Milken Institute School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OS Therapies, Inc.
 OS Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical stage therapeutic company engages in development and commercialization of treatments for osteosarcoma | Health Technology |
PR Strategies |
